Cap-Free, Hidden-Needle Onestep Lancing Pen Debuts in Spain--First Step of SteriLance's European Roll-out

What makes Onestep different What makes Onestep different In a recent evaluation with 30 frequent testers,92 %reported "little or no pain," while87 %felt safer because they never saw the needle. Market context Spainis home to an estimated5.1 million adults with diabetes, one of the highest prevalence rates inEurope. Low-pain, easy-to-use devices such as Onestep can help improve adherence to daily self-monitoring, a cornerstone of effective diabetes management...

MADRID, 10/07/2025 (informazione.news - comunicati stampa - salute e benessere)

In a recent evaluation with 30 frequent testers, reported "little or no pain," while felt safer because they never saw the needle.

Spain is home to an estimated , one of the highest prevalence rates in Europe . Low-pain, easy-to-use devices such as Onestep can help improve adherence to daily self-monitoring, a cornerstone of effective diabetes management.

Onestep and SoftSense are now on sale in Spain via . Broader retail and pharmacy distribution across additional EU markets will commence in the coming months.

Onestep and SoftSense are and certified and engineered for frequent, home-based capillary sampling.
For more information about Onestep and to explore its features, visit:
https://en.sterilance.com/innovative_products/onestep-lancing-device.
For media or distribution enquiries, please contact: . 

Photo - https://mma.prnewswire.com/media/2728413/image_5020157_8534348.jpg

View original content:https://www.prnewswire.co.uk/news-releases/cap-free-hidden-needle-onestep-lancing-pen-debuts-in-spainfirst-step-of-sterilances-european-roll-out-302502067.html